Inventor · Watertown, MA, US

Mark Cornebise

15Patents

6h-index

15Co-inventors

63Inventor score

Filing activity: Aug 14, 2000 → Sep 14, 2023

Most-cited inventions

Patent	Title	Area	Cited by	Status
US10857105B2	Compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	72	Active
US10442756B2	Compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	43	Active
US10392341B2	Compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	15	Active
US11066355B2	Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	14	Active
US11597698B2	Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	11	Active
US11220476B2	Compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	11	Active
US12151995B2	Compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	3	Active
US7034043B2	Cell adhesion inhibitors	Human Necessities	2	Expired
US6630503B1	Cell adhesion inhibitors	Human Necessities	1	Expired
US7196112B2	Cell adhesion inhibitors	Chemistry; Metallurgy	1	Expired
US12324859B2	Compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	0	Active
US8268818B2	Inhibitors of C-MET and uses thereof	Human Necessities	0	Active
US12263248B2	Compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	0	Active
US12312293B2	Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	0	Active
US12404232B2	Compounds and compositions for intracellular delivery of therapeutic agents	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.